{"page_content": "ESG R eport 2022\nThrough our pioneering leadership  in PK activation, we are  \nmaking a difference for people with genetically defined disease s\n1st Global  \nPK Deficiency  \nRegistry1st International  \nPK Deficiency  \nAdvocacy Council1st Hemolytic Anemia \nAdvocacy Coalition \nBuilding1st Clinical Trial \nEvaluating Treatment in \n\u03b1-Thalassemia1st Therapy for  \nPK Deficiency\n+ A Lot of FirstsPivotal  \nClinical Programs PublicationsDiseases with  \nPOC Achieved\nPK DEFICIENCY \nTHALASSEMIA\nSICKLE CELL DISEASE\n5", "metadata": {"source": "NASDAQ_AGIO_2021.pdf", "page": 4, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}